Lung Mass in Smokers

Academic Radiology

Volumn 24, Issue 4, 2017, Pages 386-392

  Washko, George R ^a   Kinney, Gregory L ^b   Ross, James C ^a   San José Estépar, Raúl ^a   Han, MeiLan K ^c   Dransfield, Mark T ^d   Kim, Victor ^e   Hatabu, Hiroto ^a   Come, Carolyn E ^a   Bowler, Russell P ^f   Silverman, Edwin K ^g   Crapo, James ^f   Lynch, David A ^f   Hokanson, John ^b   Diaz, Alejandro A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Food Science and Human Nutrition   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d University of Alabama at Birmingham   (United States)

^e TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f DEPARTMENT OF MEDICINE   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

Author keywords

COPD; CT scan; emphysema; Lung mass; smoking

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONE BEAM COMPUTED TOMOGRAPHY; CONE BEAM COMPUTED TOMOGRAPHY SCANNER; DISEASE SEVERITY; EMPHYSEMA; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN TISSUE; LUNG FUNCTION; LUNG PARENCHYMA; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SMOKING; AIRWAY REMODELING; CROSS-SECTIONAL STUDY; DIAGNOSTIC IMAGING; LONGITUDINAL STUDY; LUNG; LUNG EMPHYSEMA; LUNG FUNCTION TEST; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; REGRESSION ANALYSIS; STATISTICS AND NUMERICAL DATA; UNITED STATES; X-RAY COMPUTED TOMOGRAPHY;

AGED; AIRWAY REMODELING; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; LUNG; MALE; MIDDLE AGED; ORGAN SIZE; PULMONARY EMPHYSEMA; REGRESSION ANALYSIS; RESPIRATORY FUNCTION TESTS; SMOKERS; SMOKING; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 85008194210     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2016.10.011     Document Type: Article

References (32)

1. 1 Hogg, J.C., Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 364 (2004), 709–721.
2. 2 Nishimura, M., Makita, H., Nagai, K., et al. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 185 (2012), 44–52.
3. 3 Croxton, T.L., Weinmann, G.G., Senior, R.M., et al. Clinical research in chronic obstructive pulmonary disease: needs and opportunities. Am J Respir Crit Care Med 167 (2003), 1142–1149.
4. 4 Han, M.K., Agusti, A., Calverley, P.M., et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 182 (2010), 598–604.
5. 5 Coxson, H.O., Leipsic, J., Parraga, G., et al. Using pulmonary imaging to move chronic obstructive pulmonary disease beyond FEV1. Am J Respir Crit Care Med 190 (2014), 135–144.
6. 6 Rosenkrantz, A.B., Mendiratta-Lala, M., Bartholmai, B.J., et al. Clinical utility of quantitative imaging. Acad Radiol 22 (2015), 33–49.
7. 7 Hayhurst, M.D., MacNee, W., Flenley, D.C., et al. Diagnosis of pulmonary emphysema by computerised tomography. Lancet 2 (1984), 320–322.
8. 8 Muller, N.L., Staples, C.A., Miller, R.R., et al. “Density mask”. An objective method to quantitate emphysema using computed tomography. Chest 94 (1988), 782–787.
9. 9 Gevenois, P.A., De Vuyst, P., de Maertelaer, V., et al. Comparison of computed density and microscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 154 (1996), 187–192.
10. 10 Dirksen, A., Dijkman, J.H., Madsen, F., et al. A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy. Am J Respir Crit Care Med 160:5 Pt 1 (1999), 1468–1472.
11. 11 Parr, D.G., Sevenoaks, M., Deng, C., et al. Detection of emphysema progression in alpha 1-antitrypsin deficiency using CT densitometry; methodological advances. Respir Res, 9, 2008, 21.
12. 12 Vlahovic, G., Russell, M.L., Mercer, R.R., et al. Cellular and connective tissue changes in alveolar septal walls in emphysema. Am J Respir Crit Care Med 160 (1999), 2086–2092.
13. 13 Guenard, H., Diallo, M.H., Laurent, F., et al. Lung density and lung mass in emphysema. Chest 102 (1992), 198–203.
14. 14 Regan, E.A., Hokanson, J.E., Murphy, J.R., et al. Genetic epidemiology of COPD (COPDGene) study design. COPD 7 (2010), 32–43.
15. 15 Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 152 (1995), 1107–1136.
16. 16 Crapo, R.O., Morris, A.H., Gardner, R.M., Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 123 (1981), 659–664.
17. 17 Rabe, K.F., Hurd, S., Anzueto, A., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176 (2007), 532–555.
18. 18 Wan, E.S., Hokanson, J.E., Murphy, J.R., et al. Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study. Am J Respir Crit Care Med 184 (2011), 57–63.
19. 19 Bowler, R.P., Kim, V., Regan, E., et al. Prediction of acute respiratory disease in current and former smokers with and without COPD. Chest 146 (2014), 941–950.
20. 20 Diaz, A.A., Han, M.K., Come, C.E., et al. Effect of emphysema on CT scan measures of airway dimensions in smokers. Chest 143 (2013), 687–693.
21. 21 Coxson, H.O., Rogers, R.M., Whittall, K.P., et al. A quantification of the lung surface area in emphysema using computed tomography. Am J Respir Crit Care Med 159 (1999), 851–856.
22. 22 Henne, E., Anderson, J.C., Lowe, N., et al. Comparison of human lung tissue mass measurements from ex vivo lungs and high resolution CT software analysis. BMC Pulm Med, 12, 2012, 18.
23. 23 Vestbo, J., Edwards, L.D., Scanlon, P.D., et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 365 (2011), 1184–1192.
24. 24 Bartel, S.T., Bierhals, A.J., Pilgram, T.K., et al. Equating quantitative emphysema measurements on different CT image reconstructions. Med Phys 38 (2011), 4894–4902.
25. 25 Shaker, S.B., Dirksen, A., Lo, P., et al. Factors influencing the decline in lung density in a Danish lung cancer screening cohort. Eur Respir J 40 (2012), 1142–1148.
26. 26 Karimi, R., Tornling, G., Forsslund, H., et al. Lung density on high resolution computer tomography (HRCT) reflects degree of inflammation in smokers. Respir Res, 15, 2014, 23.
27. 27 Shaker, S.B., Stavngaard, T., Laursen, L.C., et al. Rapid fall in lung density following smoking cessation in COPD. COPD 8 (2011), 2–7.
28. 28 Leopold, J.G., Gough, J., The centrilobular form of hypertrophic emphysema and its relation to chronic bronchitis. Thorax 12 (1957), 219–235.
29. 29 Hogg, J.C., Chu, F., Utokaparch, S., et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350 (2004), 2645–2653.
30. 30 Stockley, R.A., Parr, D.G., Piitulainen, E., et al. Therapeutic efficacy of alpha-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry. Respir Res, 11, 2010, 136.
31. 31 Vestbo, J., Agusti, A., Wouters, E.F., et al. Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team. Am J Respir Crit Care Med 189 (2014), 1022–1030.
32. 32 Coxson, H.O., Dirksen, A., Edwards, L.D., et al. The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study. Lancet Respir Med 1 (2013), 129–136.